Am J Transplant, Volume 19, Suppl 3 Archives - Page 65 of 214 - ATC Abstracts

2019 American Transplant Congress
Integration Of Business Intelligence (BI) Solution In Tertiary Renal Transplant Centre To Drive Clinical Decisions.
M. Heer, S. Yausis, P. R. Trevillian
Newcastle Transplant Unit, John Hunter Hospital, Newcastle, Australia
*Purpose: The future of medicine will be enabled by big data. With the promise of data-driven knowledge and decision-making, innovative big-data projects are ongoing in…
2019 American Transplant Congress
A Cytomegalovirus Antiviral Stewardship Program at a Large Transplant Center
M. Jorgenson¹, J. Descourouez¹, D. Felix¹, C. Saddler², J. Smith², D. Mandelbrot²
¹UW Health, Madison, WI, ²University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI
*Purpose: The purpose of this study was to determine the feasibility and scope of a multidisciplinary cytomegalovirus Antiviral Stewardship Program.*Methods: The principles of antimicrobial stewardship…
2019 American Transplant Congress
Reduced Intensity Induction Therapy in Patients Undergoing Repeat Kidney Transplants
K. Linhares, M. Cristelli, C. Felipe, L. Viana, H. Proença, R. E. de Marco, J. Pestana, H. Tedesco
Hospital do Rim, Nephrology Division, EPM - UNIFESP, São Paulo, Brazil
*Purpose: We hypothesized that patients without donor-specific antibodies (DSA) undergoing repeat transplants could receive lower doses of antithymocyte globulin induction (rATG), without compromising efficacy and…
2019 American Transplant Congress
Outcomes Of Treatment Of Late Vs Early Acute Antibody-mediated Rejection In Renal Transplant Recipients – A Single Center Experience
R. Prashar, N. Sulejmani, A. Patel
Henry Ford Transplant Institute, Detroit, MI
*Purpose: The diagnostic accuracy and treatment options for acute antibody-mediated rejection (aABMR) in RTRs has improved over the last several years. However,response to treatment in…
2019 American Transplant Congress
Tumor Necrosis as a Result to Pre-Transplant Bridging Treatment for Hepatocellular Carcinoma and Its Effect on Post-Transplant Outcome
S. Radunz¹, A. Kirschner¹, J. M. Theysohn², C. Schotten³, T. Benkö¹
¹General, Visceral and Transplant Surgery, University Hospital Essen, Essen, Germany, ²Diagnostic and Interventional Radiology and Neurradiology, University Hospital Essen, Essen, Germany, ³Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany
*Purpose: As a bridge to liver transplantation, locoregional treatments are commonly employed in hepatocellular carcinoma (HCC) patients to prevent tumor progression during waiting time. Objective…
2019 American Transplant Congress
Early Everolimus Conversion For Renal Protection In Liver Transplantation: The Sooner The Better?
M. Tomeczkowicz, N. Sulejmani, A. Jantz, B. Summers, T. Larson, R. Salgia
Henry Ford Health System, Detroit, MI
*Purpose: Calcineurin inhibitors (CNI) are the mainstay of immunosuppressive therapy in transplantation; however, a major side effect limiting CNI use is nephrotoxicity. Mammalian target of…
2019 American Transplant Congress
Evaluating Allo-Specific CD57⁺ T Cells during Memory and Proliferative Responses
A. Lucander, H. Xu, A. Kirk
Department of Surgery, Duke University, Durham, NC
*Purpose: We have previously identified subsets of CD57+ T cells that are resistant to B7 costimulation blockade (CoB) in kidney transplant recipients. The objective of…
2019 American Transplant Congress
Kidney Transplant Outcomes in Recipients with Physical Impairments
A. G. Thomas¹, J. Ruck², N. Chu², D. Agoons², A. Shaffer², C. Haugen², H. Ying², B. Swenor², S. Norman³, J. Garonzik-Wang², D. Segev², M. McAdams-DeMarco²
¹Epidemiology, UNC Chapel Hill, Chapel Hill, NC, ²Johns Hopkins University, Baltimore, MD, ³University of Michigan, Ann Arbor, MI
*Purpose: Disability in general has been associated with poor outcomes in KT recipients. However, disability can be derived from various components, specifically visual, hearing, physical,…
2019 American Transplant Congress
Gait Speed Predicts Kidney Transplant Candidate Mortality
M. N. Harhay¹, K. Ranganna¹, L. B. Levin Mizrahi¹, G. Xiao², G. Malat², S. Guy², D. Reich², P. P. Reese³
¹Medicine, Drexel University College of Medicine, Philadelphia, PA, ²Surgery, Drexel University College of Medicine, Philadelphia, PA, ³Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA
*Purpose: Waiting list mortality is increasingly scrutinized as a metric of transplant center quality. It is unknown if gait speed assessments may augment physician evaluations…
2019 American Transplant Congress
High Health Care Utilizers in Kidney Transplantation: Do You Know Your Frequent Flyers?
E. Weeda¹, Z. Su², D. Taber³, J. Bian², T. A. Morinelli⁴, N. A. Pilch⁵, P. D. Mauldin², D. A. DuBay⁴
¹Department of Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina`, Charleston, SC, ²General Internal Medicine and Geriatrics, Medical University of South Carolina`, Charleston, SC, ³Surgery and Ralph H. Johnson VAMC, Medical University of South Carolina`, Charleston, SC, ⁴Surgery, Medical University of South Carolina`, Charleston, SC, ⁵Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina`, Charleston, SC
*Purpose: To assess high hospital inpatient [IP] admissions and emergency department [ED] utilization within a 9-month period after kidney transplantation in order to identify potential…